Swiss authorities grant product approval for Intercell's IXIARO
Vaccine to help prevent Japanese Encephalitis now available in Switzerland
Intercell AG announced that Swissmedic has approved IXIARO®,its vaccine against Japanese encephalitis. IXIARO®, which is distributed and marketed by Novartis, is now available in Switzerland.
The decision by the Swiss authorities represents another important milestone for the licensure process initiated for selected attractive market segments. Intercell's vaccine, which helps to prevent Japanese Encephalitis, has already been approved and launched in the USA, Europe, Canada and Australia.
"The Swissmedic approval is great news and another important step in the product's global reach", states Thomas Lingelbach, Chief Operating Officer of Intercell.
IXIARO® is a modern purified, inactivated vaccine for active immunization of adults against infections caused by the Japanese Encephalitis Virus. IXIARO®is manufactured at Intercell's proprietary manufacturing facility in Scotland using tissue culture rather than live organisms.
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Niels_Kaj_Jerne
CRESTOR Demonstrates CV Risk Reduction in a Large Statin Outcomes Study

Epigenetics key to daily production of 10 billion blood cells without mistakes - Study reveals a gene key for blood cell specialisation
UCLA scientists map all mammalian gene interactions

BRAIN and Südzucker intensify co-operation on functional carbohydrates

Small RNAs link immune system and brain cells - Sex-specific processes in schizophrenia and bipolar disorder

Cells adapt ultra-rapidly to zero gravity

Master hijackers: uncovering how leukaemia disarms the body’s defences - Microscopic vesicles released from leukaemia tumours and their surrounding cells prove critical in obstructing the body’s ability to fight cancer
BASF’s Nutrition & Health division to focus on growth and increased competitiveness - Reduction of about 260 positions worldwide by end of 2015
Toxicodendron_radicans

En Carta Diagnostics secures €1.5M to advance diagnostic kit platform for early Lyme disease detection - Groundbreaking patented molecular diagnostic kit poised to provide game-changing autonomous Lyme detection in minutes
